Study of Disulfiram to Reduce Myeloid Immunosuppression and Steroid Dependence in Resectable High Grade Glioma
Clinical trial NCT07719127 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07719127
- Sponsor
- Case Comprehensive Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2027-12-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.